Céline Cano

2.0k total citations
54 papers, 1.3k citations indexed

About

Céline Cano is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Céline Cano has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Organic Chemistry and 15 papers in Oncology. Recurrent topics in Céline Cano's work include Bioactive Compounds and Antitumor Agents (9 papers), Cancer therapeutics and mechanisms (9 papers) and DNA Repair Mechanisms (6 papers). Céline Cano is often cited by papers focused on Bioactive Compounds and Antitumor Agents (9 papers), Cancer therapeutics and mechanisms (9 papers) and DNA Repair Mechanisms (6 papers). Céline Cano collaborates with scholars based in United Kingdom, United States and Japan. Céline Cano's co-authors include Ian R. Hardcastle, Roger J. Griffin, Bernard T. Golding, David R. Newell, Nicola J. Curtin, Suzannah J. Harnor, Simon H. L. Thomas, M.E.M. Noble, S. Hill and Caroline J. Richardson and has published in prestigious journals such as Cancer Research, Biochemical Journal and Clinical Cancer Research.

In The Last Decade

Céline Cano

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Cano United Kingdom 21 834 387 369 118 106 54 1.3k
Stuart L. Emanuel United States 24 763 0.9× 565 1.5× 765 2.1× 69 0.6× 101 1.0× 42 1.9k
Heinz Fretz Switzerland 18 860 1.0× 358 0.9× 394 1.1× 43 0.4× 108 1.0× 38 1.2k
Hariprasad Vankayalapati United States 21 1.5k 1.8× 257 0.7× 280 0.8× 46 0.4× 81 0.8× 61 2.2k
Steven F. Bellon United States 17 1.1k 1.4× 496 1.3× 373 1.0× 52 0.4× 55 0.5× 21 1.6k
Chuangxing Guo United States 19 804 1.0× 255 0.7× 363 1.0× 51 0.4× 65 0.6× 29 1.2k
Siavosh Mahboobi Germany 26 1.0k 1.2× 369 1.0× 858 2.3× 83 0.7× 113 1.1× 76 1.8k
Kiyohiro Nishikawa Japan 21 767 0.9× 397 1.0× 348 0.9× 70 0.6× 210 2.0× 56 1.4k
Rahul Palchaudhuri United States 17 1.0k 1.2× 501 1.3× 615 1.7× 109 0.9× 67 0.6× 38 1.9k
Brian E. Fink United States 17 893 1.1× 426 1.1× 687 1.9× 109 0.9× 92 0.9× 27 1.7k
Guido Bold Switzerland 25 907 1.1× 490 1.3× 758 2.1× 39 0.3× 123 1.2× 46 1.8k

Countries citing papers authored by Céline Cano

Since Specialization
Citations

This map shows the geographic impact of Céline Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Cano more than expected).

Fields of papers citing papers by Céline Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Cano. The network helps show where Céline Cano may publish in the future.

Co-authorship network of co-authors of Céline Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Cano. A scholar is included among the top collaborators of Céline Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Cano. Céline Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cano, Céline, et al.. (2024). Polymorphism in N-(3-Hydroxyphenyl)-3-methoxybenzamide. Crystals. 14(12). 1070–1070.
2.
Miller, Duncan C., et al.. (2023). Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy. Journal of Medicinal Chemistry. 66(7). 4491–4502. 15 indexed citations
3.
Cano, Céline, et al.. (2023). A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs. Bioorganic & Medicinal Chemistry. 88-89. 117334–117334. 34 indexed citations
4.
Matheson, Christopher J., Christopher R. Coxon, Richard Bayliss, et al.. (2020). 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. RSC Medicinal Chemistry. 11(6). 707–731. 14 indexed citations
5.
Ford, Brian E., Suzannah J. Harnor, Céline Cano, et al.. (2020). Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challenge. Diabetes Obesity and Metabolism. 22(11). 1985–1994. 10 indexed citations
6.
Miller, Duncan C., Mathew P. Martin, Santosh Adhikari, et al.. (2018). Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach. Organic & Biomolecular Chemistry. 16(11). 1843–1850. 12 indexed citations
7.
Harnor, Suzannah J., et al.. (2017). Targeting DNA‐Dependent Protein Kinase for Cancer Therapy. ChemMedChem. 12(12). 895–900. 64 indexed citations
8.
Coxon, Christopher R., Christopher Wong, Richard Bayliss, et al.. (2016). Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget. 8(12). 19089–19124. 12 indexed citations
9.
Beale, Gary, Emma J. Haagensen, Huw D. Thomas, et al.. (2016). Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer. British Journal of Cancer. 115(6). 682–690. 45 indexed citations
10.
Lebraud, Honorine, Christopher R. Coxon, Benoît Carbain, et al.. (2013). Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles. Organic & Biomolecular Chemistry. 12(1). 141–148. 21 indexed citations
11.
Lebraud, Honorine, Céline Cano, Benoît Carbain, et al.. (2013). Trifluoroethanol solvent facilitates selective N-7 methylation of purines. Organic & Biomolecular Chemistry. 11(11). 1874–1874. 7 indexed citations
12.
Munck, Joanne M., Michael A. Batey, Yan Zhao, et al.. (2012). Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K. Molecular Cancer Therapeutics. 11(8). 1789–1798. 99 indexed citations
13.
Jones, Gavin O., Julia Bárdos, Bernard T. Golding, et al.. (2012). Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives. Organic & Biomolecular Chemistry. 10(33). 6747–6747. 20 indexed citations
14.
Cano, Céline, Marine Desage‐El Murr, Roger J. Griffin, et al.. (2011). Versatile synthesis of functionalised dibenzothiophenes via Suzuki coupling and microwave-assisted ring closure. Organic & Biomolecular Chemistry. 9(17). 6066–6066. 10 indexed citations
15.
Cano, Céline, et al.. (2010). Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK). Organic & Biomolecular Chemistry. 8(8). 1922–1922. 14 indexed citations
16.
Marchetti, Francesco, Céline Cano, Nicola J. Curtin, et al.. (2010). Synthesis and biological evaluation of 5-substituted O4-alkylpyrimidines as CDK2 inhibitors. Organic & Biomolecular Chemistry. 8(10). 2397–2397. 23 indexed citations
17.
Bárdos, Julia, M. Raymond V. Finlay, Bernard T. Golding, et al.. (2010). DNA-dependent protein kinase (DNA-PK) inhibitors: Structure–activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain. Bioorganic & Medicinal Chemistry Letters. 21(3). 966–970. 18 indexed citations
18.
Willmore, Elaine, Sarah L. Elliott, Tryfonia Mainou‐Fowler, et al.. (2008). DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia. Clinical Cancer Research. 14(12). 3984–3992. 73 indexed citations
19.
Albertella, Mark R., Céline Cano, Nicola J. Curtin, et al.. (2008). Identification of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors using a small-molecule library approach [abstract]. Cancer Research. 68. 4156–4156. 3 indexed citations
20.
Murr, Marine Desage‐El, Céline Cano, Bernard T. Golding, et al.. (2008). 8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK). Bioorganic & Medicinal Chemistry Letters. 18(17). 4885–4890. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart L. Emanuel Breakdown of academic impact, for papers by Heinz Fretz Breakdown of academic impact, for papers by Hariprasad Vankayalapati Breakdown of academic impact, for papers by Steven F. Bellon Breakdown of academic impact, for papers by Chuangxing Guo Breakdown of academic impact, for papers by Siavosh Mahboobi Breakdown of academic impact, for papers by Kiyohiro Nishikawa Breakdown of academic impact, for papers by Rahul Palchaudhuri Breakdown of academic impact, for papers by Brian E. Fink Breakdown of academic impact, for papers by Guido Bold
Rankless by CCL
2026